PYCARD-AS1 facilitates DNA methylation of PYCARD promotor and H3K9me2 modification by recruiting DNMT1 and G9a, resulting in the silencing of PYCARD and disruption of the apoptotic process in BC cells in vitro. Here, PYCARD is linked to breast cancer.